EAM
GILD icon

Eclectica Asset Management’s Gilead Sciences GILD Stock Holding History

Eclectica Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-9,300
Closed -$771K – 45
2014
Q2 		$771K Buy
+9,300
New +$724K 0.77% 39

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eclectica Asset Management's GILD Position: Q3 2014 in Review

Eclectica Asset Management sold out of Gilead Sciences (GILD) in Q3 2014, closing a stake of 9,300 shares — an estimated $771K sold.

Eclectica Asset Management first reported a position in GILD in Q2 2014 and held it in 1 quarter. The position peaked at $771K in Q2 2014. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • Eclectica Asset Management reported no remaining Gilead Sciences position as of Q3 2014 after selling out during the quarter.
  • Eclectica Asset Management sold 9,300 Gilead Sciences shares in Q3 2014, an estimated $771K.
  • Eclectica Asset Management first reported a position in Gilead Sciences in Q2 2014 and held it in 1 quarter.
  • Eclectica Asset Management's Gilead Sciences position peaked at $771K in Q2 2014.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on Eclectica Asset Management's 13F filing for Q3 2014, filed 12 Nov 2014.